Northern Trust Corporation Form 8.3 - Willis Towers Watson PLC (4966G)
2021年7月26日 - 11:07PM
ＲＮＳを含む英国規制内ニュース （英語）
TIDM0XHL TIDM0Y4Q
RNS Number : 4966G
Northern Trust Corporation
26 July 2021
<Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Northern Trust Corporation
(Note 1)
Company dealt in Willis Towers Watson PLC
===========================
Class of relevant security Common Stock USD 0.0033
to which the dealings
being disclosed relate
(Note 2)
===========================
Date of dealing 23(rd) July 2021
===========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities 1,409,795.00
1.10%
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total 1,409,795.00
1.10%
=================== =====================
Note: The difference in holdings from yesterday and today not
explained by transactions, can be explained by stock transfers of
19 securities into the relevant accounts .
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number Of relevant securities Price per unit ($)
BUY 2 226.41
------------------------------ -------------------
BUY 3 226.41
------------------------------ -------------------
BUY 3 226.41
------------------------------ -------------------
SELL 1 226.41
------------------------------ -------------------
BUY 2 226.41
------------------------------ -------------------
SELL 9 226.41
------------------------------ -------------------
BUY 10 226.41
------------------------------ -------------------
BUY 28 226.41
------------------------------ -------------------
SELL 4 226.41
------------------------------ -------------------
SELL 12 226.41
------------------------------ -------------------
BUY 10 226.41
------------------------------ -------------------
BUY 72 226.41
------------------------------ -------------------
BUY 2 226.41
------------------------------ -------------------
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or
relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this
should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 26(th) July 2021
Contact name London Compliance Team
=========================
Telephone number 0207 982 2158 or 0207 982
3697
=========================
If a connected EFM, name
of offeree/offeror with
which connected
=========================
If a connected EFM, state
nature of connection (Note
10)
=========================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEFLFISDVIRFIL
(END) Dow Jones Newswires
July 26, 2021 10:07 ET (14:07 GMT)
Willis Towers Watson (LSE:0Y4Q)
過去 株価チャート
から 12 2024 まで 1 2025
Willis Towers Watson (LSE:0Y4Q)
過去 株価チャート
から 1 2024 まで 1 2025
